|
RNCOS Releases a New Report- Booming Biotech Market in India
RNCOS has recently added a new Market Research Report titled, "Booming Biotech Market in India" to its report gallery. The report provides an exhaustive overview of the biotechnology market in India. It provides a detailed account of the factors that define the structure and composition of the Indian biotechnology market, making it one of the world's most potential markets.
advertisement
The report provides comprehensive information on the market size, structure, domestic consumption, exports, key segments, investment, manpower, market share of key players, drivers, restraints and present and future trends of the biotechnology market in India.
The research findings help identify the difference between the biotechnology market in India and the US and European markets in terms of factors like structure and composition, R&D, level of commercialization, and association between industry and academia that make India a preferred destination. Thus, it provides valuable information to pharmaceutical/biotech companies and investors looking to foray into the Indian market and help them devise strategies according to the Indian market.
Key Findings
- The Indian biotechnology market, valued at INR 112.6 Billion (US$ 2.86 Billion) in 2007-08, is projected to hit a CAGR of 30% in near future.
- Exports presently dominate the Indian biotechnology market, with bioservices and bioinformatics in particular being export driven industries.
- Biopharma remains India's biggest sector accounting for nearly 70% of the total revenues in 2007-08. By 2012-13, the sector is expected to be worth INR 224.13 Billion (US$ 5.7 Billion).
- The bioagriculture sector, driven by the sales of BT cotton, is the industry's fastest growing sector. Commercial approval of more transgenic plants is likely to push further growth in this sector.
- Strong R&D capability and a large patient pool for clinical trials are expected to make the bioservices sector amongst the most potential sectors in the Indian biotechnology market.
- Filliped by the surge in both R&D and production, the future of the biosupplier industry looks bright.
Key Issues and Facts Analyzed
- Evaluation of past, current and future market trends.
- Market analysis by segment.
- Discussion about the major drivers of the biotechnology market.
- Analysis of the opportunities created by the market.
- Analysis of the major challenges faced by the market.
Key Players Analyzed
This section provides the overview and key financial information on leading players in the Indian biotechnology industry, like Biocon, Serum Institute of India, Shantha Biotechnics, Bharat Serums & Vaccines, etc.
Research Methodology Used
Information Sources
Information has been sourced from various credible sources like books, newspapers, trade journals, and white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.
Analysis Method
The analysis methods include ratio analysis, historical trend analysis, linear regression analysis using software tools, judgmental forecasting, and cause and effect analysis.
About RNCOS E-Services Pvt Ltd.
RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of industry experts who analyze data collected from credible sources. They provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
For more information visit:
http://rncos.com/Report/IM110.htm
Current Industry News:
http://www.rncos.com/blog
Would you like to see your news and articles here? GO>>
Disclaimer: The views and opinions expressed in the research published are those of the individual companies and writers and not necessarily those of Investorideas.com®, or any of the industry sector portals . At the time of publication, writers may hold positions in the stocks or companies mentioned.
Investorideas.com® or any of the industry sector portals cannot assure accuracy of the research presented. Investors are encouraged to research and verify facts and under no circumstances is Investorideas.com® endorsing the content as a recommendation to buy or sell stock.
|
